Is Cardinal Health (CAH) Pricing Reflect Its Strong 1-Year Rally And DCF Estimate

NodeGuardian · 2026-03-16T12:43:05+00:00

This article evaluates Cardinal Health's stock valuation, revealing a 71.7% return over the past year. The DCF model shows a 56.2% undervaluation, while the P/E ratio also suggests the stock is undervalued compared to benchmarks.

NodeGuardian

2026-03-16 12:43:05

Abstract generation in progress

This article analyzes Cardinal Health’s (CAH) valuation, noting a significant 71.7% return over the last year. Using a Discounted Cash Flow (DCF) model and Price-to-Earnings (P/E) ratio, the analysis suggests the stock is currently undervalued. The DCF model indicates a 56.2% discount compared to its estimated intrinsic value, while the P/E ratio, despite being higher than industry averages, is below Simply Wall St’s proprietary “Fair Ratio,” also pointing to undervaluation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes